Associated Papers
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.
Chaudhary H et al.
Journal of Ovarian Research, 2021
Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology.
Dadachanji R et al.
Genetics Research International, 2018
Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.
Alshogran OY
Expert Opinion on Drug Metabolism & Toxicology, 2017
A Single Nucleotide Variant in the Promoter Region of 17β-HSD Type 5 Gene Influences External Genitalia Virilization in Females with 21-Hydroxylase Deficiency.
Kaupert LC et al.
Hormone Research in Paediatrics, 2016
17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Maier PS et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 2012
Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
Marioli DJ et al.
Fertility and Sterility, 2009
KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women.
Du X et al.
The Journal of Clinical Endocrinology and Metabolism, 2009
Select a paper to view details